GlaxoSmithKline Pharmaceuticals P/E Ratio

Current P/E Ratio
39.8
High Valuation
Very High - High growth expectations or significantly overvalued

GlaxoSmithKline Pharmaceuticals P/E ratio. GlaxoSmithKline Pharmaceuticals (GLAXO) P/E ratio is 39.8 (High), EPS (TTM) ₹61.15, current price ₹2713.40 on NSE vs historical average P/E of 40.05 (66.7th percentile) — Very High - High growth expectations or significantly overvalued. Also explore GLAXO price movement history to track price trends across different timeframes.

Current Valuation Metrics

P/E Ratio 39.8
Current Price ₹2713.40
EPS (TTM) ₹61.15
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 40.05
Historical Range 17.35 - 55.72
Percentile 66.7%

Sector Context

Sector Average 52.24
Sector Median 29.4
Sector Rank #11 of 255
Sector Percentile 4.3%

Earnings Breakdown (TTM)

TTM EPS ₹65.30
Sept 2026 ₹19.83
Mar 2026 ₹16.40

GLAXO P/E Ratio — Valuation Signal & Historical Context

GlaxoSmithKline Pharmaceuticals P/E 39.8 vs historical average 40.05, range 17.35–55.72 — signal: Overvalued. Check GLAXO company valuation to track the company's total market size over time.

  • Stock appears overvalued with PE of 39.8, suggesting caution for new investments
  • Trading at discount to sector average PE of 52.24

GlaxoSmithKline Pharmaceuticals P/E Ratio Historical Trend

GLAXO annual price-to-earnings ratio — 6 years, EPS and year-end price. Current P/E 39.8 vs historical average 40.05. For live price, revenue and the complete fundamental profile, see GlaxoSmithKline Pharmaceutical share price chart.

GLAXO Historical P/E Ratio — EPS, Year-End Price & Valuation

GlaxoSmithKline Pharmaceuticals annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 37.69 59.23 ₹2232.10 NSE High
2024 38.74 50.37 ₹1951.55 NSE High
2023 35.4 37.18 ₹1316.30 NSE High
2022 17.35 100.13 ₹1737.15 NSE Moderate
2021 55.72 28.92 ₹1611.50 NSE High
2020 55.39 29.46 ₹1631.85 NSE High

GLAXO vs Healthcare Peers — P/E Ratio Comparison

GlaxoSmithKline Pharmaceuticals P/E 39.8 vs Healthcare average 52.24, median 29.4 — range 2.0–733.0.

Sector Average
52.24
Sector Median
29.4
Lowest P/E
2.0
Highest P/E
733.0
Companies
255
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 2.0 ₹72 Low
Brooks Laboratories BROOKS 2.6 ₹206 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.3 ₹54 Low
Sun Pharma Advanced Rese… SPARC 4.1 ₹6,355 Low
Dipna Pharmachem DPL 4.5 ₹11 Low
JFL Life Sciences JFLLIFE 4.7 ₹82 Low
Royal Sense ROYAL 4.8 ₹34 Low
Star Imaging And Path Lab STARIMAGIN 5.3 ₹110 Low
Kabra Drugs KABRADG 6.3 ₹49 Low